Compare YieldMax NVDA Option Income Strategy ETF (NVDY) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
YieldMax NVDA Option Income Strategy ETF vs Sana Biotechnology Inc — how do they compare? YieldMax NVDA Option Income Strategy ETF trades at $12.58, while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). Which is the better fit depends on your goals.
| NVDY | SANA | |
|---|---|---|
Sector | Income / Options Overlay | Health |
52-Week High | $17.96 | $5.92 |
52-Week Low | $12.03 | $2.68 |
Market Cap | — | $873.84M |
Enterprise Value | — | $848.03M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About YieldMax NVDA Option Income Strategy ETF
NVDY is an actively managed ETF that pursues a synthetic covered call strategy on NVIDIA Corporation (NVDA) stock. The fund primarily sells call options on NVDA and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the high-growth potential of NVDA while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on NVDY →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
